Cargando…

Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists

Selective activation of the δ-opioid receptor (DOP) has great potential for the treatment of chronic pain, benefitting from ancillary anxiolytic and antidepressant-like effects. Moreover, DOP agonists show reduced adverse effects as compared to μ-opioid receptor (MOP) agonists that are in the spotli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Claff, Tobias, Yu, Jing, Blais, Véronique, Patel, Nilkanth, Martin, Charlotte, Wu, Lijie, Han, Gye Won, Holleran, Brian J., Van der Poorten, Olivier, White, Kate L., Hanson, Michael A., Sarret, Philippe, Gendron, Louis, Cherezov, Vadim, Katritch, Vsevolod, Ballet, Steven, Liu, Zhi-Jie, Müller, Christa E., Stevens, Raymond C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881160/ https://www.ncbi.nlm.nih.gov/pubmed/31807708 http://dx.doi.org/10.1126/sciadv.aax9115

Ejemplares similares

Structural basis for bifunctional peptide recognition at human δ-Opioid receptor
por: Fenalti, Gustavo, et al.
Publicado: (2015)

Agonist-bound structure of the human P2Y(12) receptor
por: Zhang, Jin, et al.
Publicado: (2014)

Structure of the human kappa opioid receptor in complex with JDTic
por: Wu, Huixian, et al.
Publicado: (2012)

Computational design of thermostabilizing point mutations for G protein-coupled receptors
por: Popov, Petr, et al.
Publicado: (2018)

Structure-based discovery of potent and selective melatonin receptor agonists
por: Patel, Nilkanth, et al.
Publicado: (2020)

Structural insights on ligand recognition at the human leukotriene B4 receptor 1
por: Michaelian, Nairie, et al.
Publicado: (2021)

Structural basis of the activation of a metabotropic GABA receptor
por: Shaye, Hamidreza, et al.
Publicado: (2020)

Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors
por: Gusach, Anastasiia, et al.
Publicado: (2019)

Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5
por: Beaudry, H, et al.
Publicado: (2015)

Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs
por: Luginina, Aleksandra, et al.
Publicado: (2019)

High Resolution Structure of the ba3 Cytochrome c Oxidase from Thermus thermophilus in a Lipidic Environment
por: Tiefenbrunn, Theresa, et al.
Publicado: (2011)

Structure-Based Virtual Screening of Ultra-Large Library Yields Potent Antagonists for a Lipid GPCR
por: Sadybekov, Arman A., et al.
Publicado: (2020)

Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics
por: Gadais, Charlène, et al.
Publicado: (2021)

Crystal structure of misoprostol bound to the labor inducer prostaglandin E(2) receptor
por: Audet, Martin, et al.
Publicado: (2018)

Antidepressant-like Effects of δ Opioid Receptor Agonists in Animal Models
por: Saitoh, Akiyoshi, et al.
Publicado: (2012)

Exploring Binding Properties of Agonists Interacting with a δ-Opioid Receptor
por: Collu, Francesca, et al.
Publicado: (2012)

Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist
por: Taylor, A M W, et al.
Publicado: (2015)

Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure–Activity Relationship Studies
por: Gonzalez, Simon, et al.
Publicado: (2020)

The Delta-Opioid Receptor; a Target for the Treatment of Pain
por: Quirion, Béatrice, et al.
Publicado: (2020)

In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
por: Guillemyn, Karel, et al.
Publicado: (2012)

XFEL structures of the human MT(2) melatonin receptor reveal basis of subtype selectivity
por: Johansson, Linda C., et al.
Publicado: (2019)

Structural Basis for Selectivity and Diversity in Angiotensin II Receptors
por: Zhang, Haitao, et al.
Publicado: (2017)

Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic
por: Thompson, Aaron A., et al.
Publicado: (2012)

Dynamic Strategic Bond Analysis Yields a Ten-Step Synthesis of 20-nor-Salvinorin A, a Potent κ-OR Agonist
por: Roach, Jeremy J., et al.
Publicado: (2017)

Activated microglia nibbling glycosaminoglycans from spinal cord perineural nets: a new mechanism for neuropathic pain
por: Müller, Christa E., et al.
Publicado: (2022)

The Infarct-Reducing Effect of the δ(2) Opioid Receptor Agonist Deltorphin II: The Molecular Mechanism
por: Popov, Sergey V., et al.
Publicado: (2023)

Structural basis for ligand recognition at the human MT(1) melatonin receptor
por: Stauch, Benjamin, et al.
Publicado: (2019)

Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain
por: Lagard, Camille, et al.
Publicado: (2016)

Breaking the Enigma Code of Angiotensin II Type 2 Receptor Signaling
por: Sadybekov, Anastasiia, et al.
Publicado: (2020)

Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist
por: Levy-Cooperman, N., et al.
Publicado: (2016)

A Novel G Protein–Biased Agonist at the δ Opioid Receptor with Analgesic Efficacy in Models of Chronic Pain
por: Conibear, Alexandra E., et al.
Publicado: (2020)

Elucidation of Inverse Agonist Activity of Bilastine
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2020)

It all clicks together: In silico drug discovery becoming mainstream
por: Nazarova, Antonina L., et al.
Publicado: (2022)

GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A(2A) Adenosine Receptor
por: Shiriaeva, Anna, et al.
Publicado: (2022)

δ-opioid Receptor, Microglia and Neuroinflammation
por: Xu, Yuan, et al.
Publicado: (2023)

Development of a Bioavailable μ Opioid Receptor (MOPr) Agonist, δ Opioid Receptor (DOPr) Antagonist Peptide That Evokes Antinociception without Development of Acute Tolerance
por: Mosberg, Henry I., et al.
Publicado: (2014)

Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015)

MicroRNAs in opioid addiction: elucidating evolution
por: Wood, Emily J., et al.
Publicado: (2012)

Bifunctional Peptidomimetic G Protein-Biased Mu-Opioid Receptor Agonist and Neuropeptide FF Receptor Antagonist KGFF09 Shows Efficacy in Visceral Pain without Rewarding Effects after Subcutaneous Administration in Mice
por: Dumitrascuta, Maria, et al.
Publicado: (2022)

Selective δ-Opioid Receptor Agonist, KNT-127, Facilitates Contextual Fear Extinction via Infralimbic Cortex and Amygdala in Mice
por: Kawaminami, Ayako, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ucbg6gmivdotk7ndqi9na265ue